These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 26782450)
21. Production of double repeated B subunit of Shiga toxin 2e at high levels in transgenic lettuce plants as vaccine material for porcine edema disease. Matsui T; Takita E; Sato T; Aizawa M; Ki M; Kadoyama Y; Hirano K; Kinjo S; Asao H; Kawamoto K; Kariya H; Makino S; Hamabata T; Sawada K; Kato K Transgenic Res; 2011 Aug; 20(4):735-48. PubMed ID: 20972886 [TBL] [Abstract][Full Text] [Related]
23. Oral immunization with a shiga toxin B subunit: rotavirus NSP4(90) fusion protein protects mice against gastroenteritis. Choi NW; Estes MK; Langridge WH Vaccine; 2005 Oct; 23(44):5168-76. PubMed ID: 16040169 [TBL] [Abstract][Full Text] [Related]
24. The AIDA autotransporter system is associated with F18 and stx2e in Escherichia coli isolates from pigs diagnosed with edema disease and postweaning diarrhea. Niewerth U; Frey A; Voss T; Le Bouguénec C; Baljer G; Franke S; Schmidt MA Clin Diagn Lab Immunol; 2001 Jan; 8(1):143-9. PubMed ID: 11139209 [TBL] [Abstract][Full Text] [Related]
25. Efficacy of an Escherichia coli J5 bacterin administered to primigravid heifers. Hogan JS; Bogacz VL; Aslam M; Smith KL J Dairy Sci; 1999 May; 82(5):939-43. PubMed ID: 10342231 [TBL] [Abstract][Full Text] [Related]
26. Protective immunization of mice with an active-site mutant of subtilase cytotoxin of Shiga toxin-producing Escherichia coli. Talbot UM; Paton JC; Paton AW Infect Immun; 2005 Jul; 73(7):4432-6. PubMed ID: 15972544 [TBL] [Abstract][Full Text] [Related]
33. Development of a novel live vaccine delivering enterotoxigenic Escherichia coli fimbrial antigens to prevent post-weaning diarrhea in piglets. Hur J; Lee JH Vet Immunol Immunopathol; 2012 May; 146(3-4):283-8. PubMed ID: 22417986 [TBL] [Abstract][Full Text] [Related]
34. Streptococcus suis serotype 9 bacterin immunogenicity and protective efficacy. Büttner N; Beineke A; de Buhr N; Lilienthal S; Merkel J; Waldmann KH; Valentin-Weigand P; Baums CG Vet Immunol Immunopathol; 2012 May; 146(3-4):191-200. PubMed ID: 22516423 [TBL] [Abstract][Full Text] [Related]
35. Laboratory and field trials with formalin-inactivated Escherichia coli (O78)-Pasteurella anatipestifer bacterin in white pekin ducks. Sandhu TS; Layton HW Avian Dis; 1985; 29(1):128-35. PubMed ID: 3885930 [TBL] [Abstract][Full Text] [Related]
36. Antigenicity of partial fragments of recombinant Pasteurella multocida toxin. Lee J; Woo HJ J Microbiol Biotechnol; 2010 Dec; 20(12):1756-63. PubMed ID: 21193834 [TBL] [Abstract][Full Text] [Related]
37. LEE-encoded regulator (Ler) mutants elicit serotype-specific protection, but not cross protection, against attaching and effacing E. coli strains. Zhu C; Feng S; Yang Z; Davis K; Rios H; Kaper JB; Boedeker EC Vaccine; 2007 Feb; 25(10):1884-92. PubMed ID: 17234305 [TBL] [Abstract][Full Text] [Related]
38. Immunogenicity of an oil-emulsified Escherichia coli bacterin against heterologous challenge. Gyimah JE; Panigrapy B; Hall CF; Williams JD Avian Dis; 1985; 29(2):540-5. PubMed ID: 2411251 [TBL] [Abstract][Full Text] [Related]